These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 7829624)
21. [Effects of early insulin therapy on nuclear factor kappaB pathway in skeletal muscle of diabetes: experiment with rats]. Bi Y; Sun WP; Chen X; Cai MY; Liang H; Zhu YH; He XY; Yu QQ; Li M; Weng JP Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3287-92. PubMed ID: 19159557 [TBL] [Abstract][Full Text] [Related]
22. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Henry RR; Abrams L; Nikoulina S; Ciaraldi TP Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000 [TBL] [Abstract][Full Text] [Related]
23. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Ryder JW; Yang J; Galuska D; Rincón J; Björnholm M; Krook A; Lund S; Pedersen O; Wallberg-Henriksson H; Zierath JR; Holman GD Diabetes; 2000 Apr; 49(4):647-54. PubMed ID: 10871204 [TBL] [Abstract][Full Text] [Related]
24. Normal muscle glucose uptake in mice deficient in muscle GLUT4. Fam BC; Rose LJ; Sgambellone R; Ruan Z; Proietto J; Andrikopoulos S J Endocrinol; 2012 Sep; 214(3):313-27. PubMed ID: 22736482 [TBL] [Abstract][Full Text] [Related]
25. In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle. Ryder JW; Kawano Y; Chibalin AV; Rincón J; Tsao TS; Stenbit AE; Combatsiaris T; Yang J; Holman GD; Charron MJ; Zierath JR Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):321-8. PubMed ID: 10455018 [TBL] [Abstract][Full Text] [Related]
26. Relationship between muscle fibre composition, glucose transporter protein 4 and exercise training: possible consequences in non-insulin-dependent diabetes mellitus. Daugaard JR; Richter EA Acta Physiol Scand; 2001 Mar; 171(3):267-76. PubMed ID: 11412139 [TBL] [Abstract][Full Text] [Related]
30. Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors. Kahn BB; Rosen AS; Bak JF; Andersen PH; Damsbo P; Lund S; Pedersen O J Clin Endocrinol Metab; 1992 May; 74(5):1101-9. PubMed ID: 1569156 [TBL] [Abstract][Full Text] [Related]
31. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Zisman A; Peroni OD; Abel ED; Michael MD; Mauvais-Jarvis F; Lowell BB; Wojtaszewski JF; Hirshman MF; Virkamaki A; Goodyear LJ; Kahn CR; Kahn BB Nat Med; 2000 Aug; 6(8):924-8. PubMed ID: 10932232 [TBL] [Abstract][Full Text] [Related]
32. Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes. O'Gorman DJ; Karlsson HK; McQuaid S; Yousif O; Rahman Y; Gasparro D; Glund S; Chibalin AV; Zierath JR; Nolan JJ Diabetologia; 2006 Dec; 49(12):2983-92. PubMed ID: 17019595 [TBL] [Abstract][Full Text] [Related]
33. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats. Park SY; Choi GH; Choi HI; Ryu J; Jung CY; Lee W Arch Biochem Biophys; 2005 Apr; 436(2):276-84. PubMed ID: 15797240 [TBL] [Abstract][Full Text] [Related]
34. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. Kim JK; Zisman A; Fillmore JJ; Peroni OD; Kotani K; Perret P; Zong H; Dong J; Kahn CR; Kahn BB; Shulman GI J Clin Invest; 2001 Jul; 108(1):153-60. PubMed ID: 11435467 [TBL] [Abstract][Full Text] [Related]
35. Insulin action in skeletal muscle from patients with NIDDM. Zierath JR; Krook A; Wallberg-Henriksson H Mol Cell Biochem; 1998 May; 182(1-2):153-60. PubMed ID: 9609124 [TBL] [Abstract][Full Text] [Related]
36. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Cooksey RC; Hebert LF; Zhu JH; Wofford P; Garvey WT; McClain DA Endocrinology; 1999 Mar; 140(3):1151-7. PubMed ID: 10067838 [TBL] [Abstract][Full Text] [Related]
37. GLUT4 overexpression in db/db mice dose-dependently ameliorates diabetes but is not a lifelong cure. Brozinick JT; McCoid SC; Reynolds TH; Nardone NA; Hargrove DM; Stevenson RW; Cushman SW; Gibbs EM Diabetes; 2001 Mar; 50(3):593-600. PubMed ID: 11246879 [TBL] [Abstract][Full Text] [Related]
38. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Carvalho E; Kotani K; Peroni OD; Kahn BB Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E551-61. PubMed ID: 15928024 [TBL] [Abstract][Full Text] [Related]
39. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects. Christ-Roberts CY; Pratipanawatr T; Pratipanawatr W; Berria R; Belfort R; Kashyap S; Mandarino LJ Metabolism; 2004 Sep; 53(9):1233-42. PubMed ID: 15334390 [TBL] [Abstract][Full Text] [Related]
40. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. Garvey WT; Maianu L; Zhu JH; Brechtel-Hook G; Wallace P; Baron AD J Clin Invest; 1998 Jun; 101(11):2377-86. PubMed ID: 9616209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]